The uterine fibroids are the most common benign tumors found in the female reproductive system. Uterine fibroids commonly cause heavy menstrual periods. The prevalence of uterine fibroids is significantly affecting up to 70-80% of women by the age of 50, with an inconsistent impact on women of African origin. Carbitocin is a synthetic analogue of oxytocin which has a longer half-life than oxytocin. A Cochrane review and meta-analysis studies found that carbitocin reduced the use of additional uterotonics and transfusion. However, few of these studies was done during myomectomy.
Inclusion Criteria:
Exclusion Criteria:
darlingtonpeter2012@gmail.com
Both the participants, investigator and the assessor of the outcomes will be masked.
only the anesthetic that will be administering the drugs or placebo will know the drug
will receive 100μg intravenous carbetocin at induction of anesthesia
will receive intravenous placebo (Injection water).
vegorsafeway@gmail.com08033037685
the Effect of Carbetocin in Decreasing Intraoperative Blood Loss in Abdominal Myomectomy
Intraoperative Carbetocin to Decrease Blood Loss During Hysteroscopic Myomectomy
Evaluating Efficacy of Intravenous Carbetocin Versus Intramyometrial Injection of Adrenaline in Reducing Blood Loss
Ergometrine Versus Carbetocin to Decrease Blood Loss in Myomectomy
Methods to Reduce Blood Loss in Abdominal Myomectomy
The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Using Haemostatic Tourniquets:
The Effect of Intramyometrial Injection of Terlipressin Versus Intramyometrial Injection of Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations
The Effect of Intracapsular Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations